title: Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
authors.forename: N C
authors.initials: NC
authors.lastname: Tassopoulos
authors.forename: A E
authors.initials: AE
authors.lastname: Hatzakis
authors.forename: G V
authors.initials: GV
authors.lastname: Papatheodoridis
authors.forename: G
authors.initials: G
authors.lastname: Karvountzis
authors.forename: H
authors.initials: H
authors.lastname: Troonen
authors.forename: L
authors.initials: L
authors.lastname: Lennartz
mesh_terms: D000328:Adult; D002908:Chronic Disease; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000628:therapy*; D018937:Hepatitis C Antibodies; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D016898:Interferon-alpha / Q000627:therapeutic use*
chemical_list: D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D007075:Immunoglobulin M; D016898:Interferon-alpha